Keros Therapeutics, Inc.KROSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
29.55%
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-15198.77%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 29.55% | +100.6% |
| 2024 | -5234.48% | +94.8% |
| 2023 | -100779.47% | - |
| 2022 | 0.00% | +100.0% |
| 2021 | -280.35% | -135.8% |
| 2019 | -118.90% | -1436.2% |
| 2018 | -7.74% | - |